HIGHLIGHTS
- who: Cornelia Kolberg-Liedtke from the Department of Gynecology and Obstetrics, University Hospital Essen, Hufelandstrasse, Essen, Germany have published the article: Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial, in the Journal: (JOURNAL) of January/25,/2013
- what: The randomized prospective WSG-ADAPT TN phase II trial was designed to compare efficacy of carboplatin versus gemcitabine (each in combination with a nabpaclitaxel backbone) as a 12-week anthracycline-free chemotherapy regimen. pCR rates were higher in the carboplatin arm . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.